ROCKEFELLER UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Exploratory Study of Melatonin Induced Sleep Regularization in Severe Brain Injury

Not Applicable

Terminated

Conditions: Disorders of Consciousness

Interventions: Dietary Supplement: melatonin

First Posted Date: 2016-04-08

Last Posted Date: 2023-05-30

Lead Sponsor: Rockefeller University

Target Recruit Count: 1

Registration Number: NCT02732288

Locations: 🇺🇸
The Rockefeller University, New York, New York, United States

Using Genomic Analysis to Guide Individual Treatment in Glioblastoma

Completed

Conditions: Glioblastoma

Interventions: Other: Observational study, no intervention

First Posted Date: 2016-04-01

Last Posted Date: 2017-10-25

Lead Sponsor: Rockefeller University

Target Recruit Count: 36

Registration Number: NCT02725684

Locations: 🇺🇸
New York University Langone Medical Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Rockefeller University, New York, New York, United States

and more 4 locations

Impact of Metabolic Syndrome on Flu Vaccine Efficacy

Not Applicable

Terminated

Conditions: Metabolic Syndrome
Immune Deficiency

Interventions: Biological: Influenza vaccine

First Posted Date: 2016-01-12

Last Posted Date: 2017-09-28

Lead Sponsor: Rockefeller University

Target Recruit Count: 17

Registration Number: NCT02653495

Locations: 🇺🇸
Rockefeller University, New York, New York, United States

Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination

Not Applicable

Terminated

Conditions: Hepatitis C

Interventions: Drug: Zoster vaccine live

First Posted Date: 2015-10-28

Last Posted Date: 2019-12-18

Lead Sponsor: Rockefeller University

Target Recruit Count: 14

Registration Number: NCT02590068

Locations: 🇺🇸
Rockefeller University Hospital, New York, New York, United States

A Study of the Safety and Antiretroviral Activity of 3BNC117

Phase 2

Completed

Conditions: HIV-1 Infection

Interventions: Drug: 3BNC117
Other: Antiretroviral Treatment Interruption

First Posted Date: 2015-10-28

Last Posted Date: 2021-06-16

Lead Sponsor: Rockefeller University

Target Recruit Count: 17

Registration Number: NCT02588586

Locations: 🇺🇸
Weill Cornel Medical Center, New York, New York, United States
🇺🇸
The Rockefeller University, New York, New York, United States

Study of the Reversibility of Glucose Intolerance Caused by Chronic Aspartame Consumption

Not Applicable

Completed

Conditions: Glucose Metabolism Disorder

Interventions: Other: Oral glucose tolerance test (OGTT)
Other: Diet soda containing aspartame only

First Posted Date: 2015-08-11

Last Posted Date: 2020-06-04

Lead Sponsor: Rockefeller University

Target Recruit Count: 75

Registration Number: NCT02520258

Locations: 🇺🇸
The Rockefeller University, New York, New York, United States

A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074

Phase 1

Completed

Conditions: Healthy
HIV

Interventions: Biological: 30 mg/kg, single dose IV administration of 10-1074
Biological: 10 mg/kg, single dose IV administration of 10-1074
Biological: 3 mg/kg, single dose IV administration of 10-1074

First Posted Date: 2015-07-30

Last Posted Date: 2018-02-05

Lead Sponsor: Rockefeller University

Target Recruit Count: 33

Registration Number: NCT02511990

Locations: 🇺🇸
The Rockefeller University, New York, New York, United States
🇩🇪
University of Cologne, Cologne, Germany

Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)

Completed

Conditions: Melanoma

First Posted Date: 2015-06-12

Last Posted Date: 2023-05-24

Lead Sponsor: Rockefeller University

Target Recruit Count: 143

Registration Number: NCT02470273

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
🇺🇸
The University of California (Davis), Sacramento, California, United States
🇺🇸
Beckman Laser Institute at University of California Irvine, Irvine, California, United States

and more 2 locations

3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption

Phase 2

Completed

Conditions: HIV-1 Infection

Interventions: Drug: 3BNC117
Other: ART Interruption

First Posted Date: 2015-05-18

Last Posted Date: 2020-07-23

Lead Sponsor: Rockefeller University

Target Recruit Count: 16

Registration Number: NCT02446847

Locations: 🇺🇸
The Rockefeller University, New York, New York, United States

Effects of Persistent Innate Immune Activation on Vaccine Efficacy

Phase 4

Terminated

Conditions: Hepatitis C Infection

Interventions: Drug: Recombivax

First Posted Date: 2015-04-29

Last Posted Date: 2020-03-04

Lead Sponsor: Rockefeller University

Target Recruit Count: 24

Registration Number: NCT02429583

Locations: 🇺🇸
Rockefeller University Hospital, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy